Campbell & Co Investment Adviser’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
92,153
+45,772
+99% +$1.06M 0.12% 268
2026
Q1
$954K Buy
+46,381
New +$1.05M 0.05% 520
2025
Q3
Sell
-67,455
Closed -$1.55M 1338
2025
Q2
$1.55M Buy
+67,455
New +$1.56M 0.1% 324

Other funds holding PRVA

Campbell & Co Investment Adviser's PRVA Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Privia Health (PRVA) stake by 99% in Q2 2026, buying an estimated $1.06M and bringing the position to 92,153 shares worth $2.37M. The position accounts for 0.12% of the portfolio, ranked #268.

Campbell & Co Investment Adviser first reported a position in PRVA in Q2 2025 and has held it in 3 quarters since. 73 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Campbell & Co Investment Adviser held 92,153 shares of Privia Health worth $2.37M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 45,772 Privia Health shares in Q2 2026, an estimated $1.06M.
  • Privia Health made up 0.12% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #268 holding.
  • Campbell & Co Investment Adviser first reported a position in Privia Health in Q2 2025 and has held it in 3 quarters since.
  • 73 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.